메뉴 건너뛰기




Volumn 18, Issue 3, 2000, Pages 253-259

Phase II trial of liposomal doxorubicin (Doxil®) in advanced soft tissue sarcomas

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; LIPOSOME;

EID: 0033879520     PISSN: 01676997     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006429907449     Document Type: Article
Times cited : (46)

References (29)
  • 3
    • 0015987706 scopus 로고
    • Adriamycin chemotherapy - Efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule
    • Benjamin RS, Wiernik PH, Bachur NR: Adriamycin chemotherapy - efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule. Cancer 33: 19-27, 1974
    • (1974) Cancer , vol.33 , pp. 19-27
    • Benjamin, R.S.1    Wiernik, P.H.2    Bachur, N.R.3
  • 4
    • 0020354811 scopus 로고
    • A comparison of adriamycin versus vincristine and adriamycin, and cyclophosphamide versus vincristine, actinomycin-D, and cyclophosphamide for advanced sarcoma
    • Schoenfeld DA, Rosenbaum C, Horton J, Wolter JW, Falkson G, DeConti RC: A comparison of adriamycin versus vincristine and adriamycin, and cyclophosphamide versus vincristine, actinomycin-D, and cyclophosphamide for advanced sarcoma. Cancer 50: 2757-2762, 1982
    • (1982) Cancer , vol.50 , pp. 2757-2762
    • Schoenfeld, D.A.1    Rosenbaum, C.2    Horton, J.3    Wolter, J.W.4    Falkson, G.5    DeConti, R.C.6
  • 5
    • 0025150176 scopus 로고
    • Randomized comparison of doxorubicin and vindesine to doxorubicin for patients with metastatic soft-tissue sarcomas
    • Borden EC, Amato DA, Edmonson JK, Ritch PS, Shiraki M: Randomized comparison of doxorubicin and vindesine to doxorubicin for patients with metastatic soft-tissue sarcomas. Cancer 66: 862-867, 1990
    • (1990) Cancer , vol.66 , pp. 862-867
    • Borden, E.C.1    Amato, D.A.2    Edmonson, J.K.3    Ritch, P.S.4    Shiraki, M.5
  • 6
    • 0027256397 scopus 로고
    • Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas
    • Edmonson JH, Ryan LM, Blum RH, Brooks JS, Shiraki M, Frytak S, Parkinson DR: Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas. J Clin Oncol 11: 1269-1275, 1993
    • (1993) J Clin Oncol , vol.11 , pp. 1269-1275
    • Edmonson, J.H.1    Ryan, L.M.2    Blum, R.H.3    Brooks, J.S.4    Shiraki, M.5    Frytak, S.6    Parkinson, D.R.7
  • 8
    • 0023235065 scopus 로고
    • Combination chemotherapy using adriamycin, DTIC, cyclophosphamide, and actinomycin D for advanced soft tissue sarcomas: A randomized comparative trial
    • A phase III, Southwest Oncology Group Study (7613)
    • Baker LH, Frank J, Fine G, Balcerzalk SP, Stephens RL, Stuckey WJ, Rivkin S, Saiki J, Ward JH: Combination chemotherapy using adriamycin, DTIC, cyclophosphamide, and actinomycin D for advanced soft tissue sarcomas: a randomized comparative trial. A phase III, Southwest Oncology Group Study (7613). J Clin Oncol 5: 851-861, 1987
    • (1987) J Clin Oncol , vol.5 , pp. 851-861
    • Baker, L.H.1    Frank, J.2    Fine, G.3    Balcerzalk, S.P.4    Stephens, R.L.5    Stuckey, W.J.6    Rivkin, S.7    Saiki, J.8    Ward, J.H.9
  • 9
    • 0026487406 scopus 로고
    • Intra-arterial adriamycin, conventionally fractionated radiotherapy and conservative surgery for soft tissue sarcomas
    • Mason M, Robinson W, Harmer C, Westbury G: Intra-arterial adriamycin, conventionally fractionated radiotherapy and conservative surgery for soft tissue sarcomas. Clin Oncol (R Coll Radiol) 4: 32-35, 1992
    • (1992) Clin Oncol (R Coll Radiol) , vol.4 , pp. 32-35
    • Mason, M.1    Robinson, W.2    Harmer, C.3    Westbury, G.4
  • 11
    • 0027162899 scopus 로고
    • Prolongation of the circulation time of doxorubicin encapsulated in liposomes containing a polyethylene glycol-derivatized phospholipid: Pharmacokinetic studies in rodents and dogs
    • Gabizon AA, Barenholz Y, Bialer M: Prolongation of the circulation time of doxorubicin encapsulated in liposomes containing a polyethylene glycol-derivatized phospholipid: pharmacokinetic studies in rodents and dogs. Pharm Res 10: 703-708, 1993
    • (1993) Pharm Res , vol.10 , pp. 703-708
    • Gabizon, A.A.1    Barenholz, Y.2    Bialer, M.3
  • 12
    • 0028349925 scopus 로고
    • Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes
    • Gabizon A, Catane R, Uziely B, Kaufman B, Safra T, Cohen R, Martin F, Huang A, Barenhoiz Y: Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res 54: 987-992, 1994
    • (1994) Cancer Res , vol.54 , pp. 987-992
    • Gabizon, A.1    Catane, R.2    Uziely, B.3    Kaufman, B.4    Safra, T.5    Cohen, R.6    Martin, F.7    Huang, A.8    Barenhoiz, Y.9
  • 13
    • 0030024958 scopus 로고    scopus 로고
    • Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: Pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma
    • Northfelt DW, Martin FJ, Working P, Volberding PA, Russell J, Newman M, Amantea MA, Kaplan LD: Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma. J Clin Pharmacol 36: 55-63, 1996
    • (1996) J Clin Pharmacol , vol.36 , pp. 55-63
    • Northfelt, D.W.1    Martin, F.J.2    Working, P.3    Volberding, P.A.4    Russell, J.5    Newman, M.6    Amantea, M.A.7    Kaplan, L.D.8
  • 14
    • 0025731906 scopus 로고
    • Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo
    • Alien TM, Hansen C, Martin F, Redemann C, Yau-Young A: Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim Biophys Acta 1066: 29-36, 1991
    • (1991) Biochim Biophys Acta , vol.1066 , pp. 29-36
    • Alien, T.M.1    Hansen, C.2    Martin, F.3    Redemann, C.4    Yau-Young, A.5
  • 16
    • 0025740783 scopus 로고
    • Sensitization of multidrug-resistant colon cancer cells to doxorubicin encapsulated in liposomes
    • Oudard S, Thierry A, Jorgensen TJ, Rahman A: Sensitization of multidrug-resistant colon cancer cells to doxorubicin encapsulated in liposomes. Cancer Chemother Pharmacol 28: 259-265, 1991
    • (1991) Cancer Chemother Pharmacol , vol.28 , pp. 259-265
    • Oudard, S.1    Thierry, A.2    Jorgensen, T.J.3    Rahman, A.4
  • 17
    • 0026808970 scopus 로고
    • Effect of liposomes on P-glycoprotein function in multidrug resistant cells
    • Thierry AR, Dritschilo A, Rahman A: Effect of liposomes on P-glycoprotein function in multidrug resistant cells. Biochem Biophys Res Commun 187: 1098-1105, 1992
    • (1992) Biochem Biophys Res Commun , vol.187 , pp. 1098-1105
    • Thierry, A.R.1    Dritschilo, A.2    Rahman, A.3
  • 18
    • 0031822413 scopus 로고    scopus 로고
    • The use of cardiac biopsy to demonstrate reduced cardiotoxicity in AIDS Kaposi's sarcoma patients treated with pegylated liposomal doxorubicin
    • Berry G, Billingham M, Alderman E, Richardson P, Torti F, Lum B, Patek A, Martin FJ: The use of cardiac biopsy to demonstrate reduced cardiotoxicity in AIDS Kaposi's sarcoma patients treated with pegylated liposomal doxorubicin. Ann Oncol 9:711-716, 1998
    • (1998) Ann Oncol , vol.9 , pp. 711-716
    • Berry, G.1    Billingham, M.2    Alderman, E.3    Richardson, P.4    Torti, F.5    Lum, B.6    Patek, A.7    Martin, F.J.8
  • 20
    • 0031861021 scopus 로고    scopus 로고
    • Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: Results of a randomized phase III clinical trial
    • Northfelt DW, Dezube BJ, Thommes JA, Miller BJ, Fischl MA, Friedman-Kien A, Kaplan LD, Du Mond C, Mamelok RD, Henry DH: Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial. J Clin Oncol 16: 2445-2451, 1998
    • (1998) J Clin Oncol , vol.16 , pp. 2445-2451
    • Northfelt, D.W.1    Dezube, B.J.2    Thommes, J.A.3    Miller, B.J.4    Fischl, M.A.5    Friedman-Kien, A.6    Kaplan, L.D.7    Du Mond, C.8    Mamelok, R.D.9    Henry, D.H.10
  • 22
    • 0031941991 scopus 로고    scopus 로고
    • Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma
    • International Pegylated Liposomal Doxorubicin Study Group
    • Stewart S, Jablonowski H, Goebel FD, Arasteh K, Spittle M, Rios A, Aboulafia D, Galleshaw J, Dezube BJ: Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group, J Clin Oncol 16: 683-691, 1998
    • (1998) J Clin Oncol , vol.16 , pp. 683-691
    • Stewart, S.1    Jablonowski, H.2    Goebel, F.D.3    Arasteh, K.4    Spittle, M.5    Rios, A.6    Aboulafia, D.7    Galleshaw, J.8    Dezube, B.J.9
  • 23
    • 0030959798 scopus 로고    scopus 로고
    • Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: Results of a multicenter phase II trial
    • Ranson MR, Carmichael J, O'Byrne K, Stewart S, Smith D, Howell A: Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: results of a multicenter phase II trial [see comments]. J Clin Oncol 15: 3185-3191, 1997
    • (1997) J Clin Oncol , vol.15 , pp. 3185-3191
    • Ranson, M.R.1    Carmichael, J.2    O'Byrne, K.3    Stewart, S.4    Smith, D.5    Howell, A.6
  • 25
    • 0031795043 scopus 로고    scopus 로고
    • A phase II study of Doxil (liposomal doxorubicin): Lack of activity in poor prognosis soft tissue sarcomas
    • Garcia AA, Kempf RA, Rogers M, Muggia FM: A phase II study of Doxil (liposomal doxorubicin): lack of activity in poor prognosis soft tissue sarcomas. Ann Oncol 9: 1131-1133, 1998
    • (1998) Ann Oncol , vol.9 , pp. 1131-1133
    • Garcia, A.A.1    Kempf, R.A.2    Rogers, M.3    Muggia, F.M.4
  • 26
    • 0013170748 scopus 로고    scopus 로고
    • A phase II trial of pegylated liposomal doxorubicin (Doxil) demonstrates activity in refractory sarcoma, mesothelioma, and head and neck cancer
    • abstract 2090
    • Skubitz K: A phase II trial of pegylated liposomal doxorubicin (Doxil) demonstrates activity in refractory sarcoma, mesothelioma, and head and neck cancer. Proc Am Soc Clin Oncol 18: 541a (abstract 2090), 1999
    • (1999) Proc am Soc Clin Oncol , vol.18
    • Skubitz, K.1
  • 27
    • 0005755484 scopus 로고    scopus 로고
    • Liposomal doxorubicin (CAELYX) in advanced pretreated soft tissue sarcomas (STS): A phase II trial of the Italian sarcoma group (ISG)
    • abstract 2087
    • Toma S, Tucci A, Villani G, Carteni G, Palumbo R: Liposomal doxorubicin (CAELYX) in advanced pretreated soft tissue sarcomas (STS): a phase II trial of the Italian sarcoma group (ISG). Proc Am Soc Clin Oncol 18: 540a (abstract 2087), 1999
    • (1999) Proc am Soc Clin Oncol , vol.18
    • Toma, S.1    Tucci, A.2    Villani, G.3    Carteni, G.4    Palumbo, R.5
  • 29
    • 0030994523 scopus 로고    scopus 로고
    • Phase I trial of dose-intense liposome-encapsulated doxorubicin in patients with advanced sarcoma
    • Casper ES, Schwartz GK, Sugarman A, Leung D, Brennan MF: Phase I trial of dose-intense liposome-encapsulated doxorubicin in patients with advanced sarcoma. J Clin Oncol 15: 2111-2117, 1997
    • (1997) J Clin Oncol , vol.15 , pp. 2111-2117
    • Casper, E.S.1    Schwartz, G.K.2    Sugarman, A.3    Leung, D.4    Brennan, M.F.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.